immatics and Roche sign cancer vaccine and immunotherapy collaboration
Collaboration spans the discovery, development and commercialisation of cancer vaccines and other cancer immunotherapies in gastric, lung and prostate cancer
18-Nov-2013 -
immatics biotechnologies GmbH and Roche announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.
The agreement will focus on the research, clinical development and commercialisation of a number of new tumour-associated peptide ...
cancer
gastric cancer
immunotherapies
+4